DSS - Mergers and acquisitions

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS, "Company"))), a multinational company operating across four distinct market sectors, announced today a significant investment by its Chairman of the Board, Heng Fai Ambrose Chan. In a strategic move to bolster shareholder confidence and underscore his commitment to the company's growth. Chairman Chan acquired an additional 672,173 shares of DS, Inc. in an open market transaction on December 28, 2023.  Frank Heuszel, CEO of DSS, Inc., expressed his enthusiasm for Mr. Chan's increased stake, viewing it as a strong vote of confidence in the company's strategic direction and future potential. Heuszel said, "Chairman Chan's decis

NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS, "Company"))), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, today announced that it will proceed with a 1-for-20 reverse stock split (the "Reverse Split") of its issued and outstanding shares of common stock, par value $0.02, following authorization by its Board of Directors and majority shareholders to effect a reverse split by a ratio of not less than 1-for-20 and not more than 1-for-40 (the "Reverse Split Range"), at any time on or before April 20, 2024, with the Board having the discre

NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that its wholly-owned subsidiary, Premier Packaging, signed a contract extension with an existing client for the next three years totaling a minimum of $12 Million with a fourth year extension option bringing the potential total revenue to over $15 Million. Frank D. Heuszel, President and CEO of DSS, Inc., said, "We are very pleased to see that our capital investment to increase production capacity and economies of scale at

NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc. ("the Company" and "Impact") announced today that the Company filed a Current Report on Form 8-K with the Securities and Exchange Commission on November 6, 2023, disclosing that DSS BioHealth Security, Inc. ("DBH"), a subsidiary of DSS, Inc. (NYSE:DSS), converted substantially all of its 87.5% common stock equity interest in Impact into an equivalent number of Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock can be converted back to Impact common stock 75 days after October 31, 2023. Impact executed a reverse stock split (1 for 55) of its issued and outstanding common stock, but did not effec

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) announced today that, in a unan​i​mous decision, the Court of Appeals for the Federal Circuit (CAFC) rejected Nichia Corp.'s challenge to U.S. Patent No. 6,879,040 (the ‘040 Patent). U.S. Chief Circuit Judge Kimberly Moore, who authored the opinion, and U.S. Circuit Judges Kara Stoll and Tiffany Cunningham sat on the panel for the Federal Circuit. The CAFC appeal mounted by Nichia Corp., a Japanese electronics company, asserted that a 2021 Inter Partes Review (IPR) decision by the USPTO Patent Trial and Appeal Board declaring the ‘040 Patent to be valid should be overturned. The arguments put forth by Nichia were soundly d

NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) announced today that Impact BioMedical Inc. ("Impact") filed a Current Report on Form 8-K with the Securities and Exchange Commission on November 6, 2023, disclosing that Impact effected a reverse stock split of its issued and outstanding common stock by a ratio of 1 for 55. Impact did not effectuate a reverse split of its authorized capital stock and no amendment to the articles of incorporation or bylaws was made. Impact received approval from its majority stockholder and the Company's Board of Directors to effectuate the reverse split. In addition to the reverse split, Impact's Form 8-K discloses DSS BioHealth Security,

NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE:DSS) announced today that the Company received a letter (the "Letter") from the staff of NYSE American LLC (the "Exchange") stating that the Company's securities have been selling for a low price per share for a substantial period of time and, pursuant to Section 1003(f)(v) of the NYSE American Company Guide. The Company's continued listing is predicated on it effecting a reverse stock split of its common stock or otherwise demonstrating sustained price improvement within a reasonable period of time, which the Exchange has determined to be no later than April 20, 2024. On October 26, 2023, the Company notified the Exchan

ROCHESTER, N.Y., Sept. 06, 2023 (GLOBE NEWSWIRE) -- DSS Wealth Management, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce that Jim Monaghan has joined as Chief Operating Officer and Chief Compliance Officer and Michael Cheah has joined DSS Wealth Management in the role of Portfolio Manager & Head of Fixed Income. Jim Monaghan has joined DSS Wealth Management as Chief Operating Officer and Chief Compliance Officer reporting to Daniel Lew. Mr. Monaghan has over 30 years working in the investment industry holding several leadership positions at industry leading financial firms. He started his career in the annuity busin

ROCHESTER, N.Y., June 30, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, has filed for the distribution of a special stock dividend of Impact Biomedical Inc. to DSS Inc. shareholders of record on July 10, 2023, pending SEC clearance. DSS shareholders of record as of 5:00 p.m. ET on July 10, 2023 (the "record date") will be entitled to four (4) shares of Impact Biomedical Inc. for every one (1) share of DSS on the distribution date. The distribution date is to be determined. The distribution is subject to the

ROCHESTER, N.Y., June 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, has filed for the distribution of a special stock dividend to DSS Inc. shareholders of record on June 30 for distribution on July 14, 2023. DSS shareholders of record as of 4:00 p.m. ET on June 30, 2023 (the "record date") will receive four (4) shares of Impact Biomedical, Inc. for every one (1) share of DSS. About Impact BioMedical, Inc. Impact BioMedical, Inc. ("Impact BioMedical") is a wholly owned subsidiary of DSS. Impact BioMedi

ROCHESTER, N.Y., May 01, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, announced today the distribution date for the common stock of Sharing Services Global Corporation ("Sharing Services" or "SHRG") that is beneficially held by DSS, directly and through its subsidiary, Decentralized Sharing Systems, Inc. ("DSSI"). As previously announced, DSS Inc., together with its subsidiary DSSI, distributed (the "Distribution") approximately 280 million shares of Sharing Services' common stock beneficially held by DSS a

ROCHESTER, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, announced that the Company plans to distribute to its stockholders common stock of Sharing Services Global Corporation ("Sharing Services" or "SHRG") that is beneficially held by DSS, directly and through its subsidiary, Decentralized Sharing Systems, Inc. ("DSSI"). Sharing Services is a diversified direct marketing company that is currently listed on the OTC (OTC:SHRG) and is in the process of up-listing to Nasdaq. As a major shareh

ROCHESTER, N.Y., March 02, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating nine business divisions through strategic acquisitions and development to enrich shareholder value, today announced a letter to shareholders. Dear Shareholders: I want to begin by thanking you, our shareholders, for your continued support as we execute our vision of a decentralized sharing business model to build shareholder value and drive exponential growth. In my last letter to shareholders, I said 2022 was forecasted to be a breakout year for DSS. I am pleased to report that our team delivered on this objective as we excelled under the first year

ROCHESTER, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced it received a notice (the "Notice") stating that the Company is not in compliance with the NYSE American's continued listing requirements under the timely filing criteria established in the NYSE American Company Guide. Under Section 1007 of the NYSE American Company Guide, the Company could be granted up to 12 months to cure the late filer deficiency. The initial six mont

ROCHESTER, N.Y., July 26, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced that less than a year after successfully synthesizing its first Quantum-based compound, Impact Biomedical, Inc. and its research partner Global Research and Discovery Group Sciences (GRDG) developed a Quantum antihistamine that could shift how medicine is administered while moving the pharmaceutical industry away from an impending patent cliff. "What this represents in

ROCHESTER, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced Global BioLife, Inc. ("Global BioLife"), a subsidiary of the Company's wholly owned subsidiary Impact BioMedical, Inc. ("Impact BioMedical"), executed a license agreement with ProPhase BioPharma, Inc. ("PBIO"), a subsidiary of ProPhase Labs, Inc. (NASDAQ:PRPH), a rapidly growing and diversified diagnostics, genomics and biotech company, for Global BioLife's Linebacker por

HENRIETTA, N.Y., June 07, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced Global BioLife, Inc. ("Global BioLife"), a division of the Company's wholly owned subsidiary Impact BioMedical, was granted a patent (No. 2020119933780) from the China National Intellectual Property Administration ("CNIPA") for 3F™, a Functional Fragrance Formulation (3F™) technology that is effective as a mosquito repellant through a fragrant com

ROCHESTER, N.Y., May 06, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced that an interview with Chief Operating Officer, Jason Grady, will air on The RedChip Money Report® on Bloomberg U.S., this Saturday May 7th, at 7 p.m. Eastern Time (ET). Bloomberg U.S. is available in an estimated 73 million homes across the United States. The RedChip Money Report® is produced by RedChip Companies Inc., an international Investor Relations and media

DSS adds True Partner Capital with $1.7B AUM into DSS Securities; greatly enhancing the portfolio of the finance and asset management division of DSS ROCHESTER, N.Y., Jan. 19, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company with nine operating business lines in diverse, high-growth industries, entered into a stock purchase agreement (the "AIL Subscription Agreement") on January 18, 2022, with its shareholder Alset EHome International Inc. ("AEI"), which currently owns 15.24% of the Company's outstanding shares of common stock, pursuant to which AEI sold to the Company 877,248,065 ordinary shares, no par value per share, of Alset Internationa

ROCHESTER, N.Y., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, today announced it signed a subscription agreement for a $40 million investment in American Pacific Bancorp ("APB"). Pursuant to the subscription agreement, APB will issue 6,666,700 shares of its common stock to DSS at $6.00 per share. "APB has assembled a strong pipeline of diversified loans from home mortgages, licensed medical real estate financing, district bonds, SME loans, conve